Irritable Bowel Syndrome News

WASHINGTON — Fecal microbiota transplantation altered the gut microbiota of patients with irritable bowel syndrome, but it was not superior to placebo for improving symptoms in a study presented at Digestive Disease Week.

WASHINGTON — Fecal microbiota transplantation improved symptoms in patients with refractory irritable bowel syndrome with severe abdominal bloating, according to research presented here.

WASHINGTON — Patients with constipation predominant irritable bowel syndrome are more likely to experience pelvic floor-related distress compared to others with chronic constipation, according to research presented at Digestive Disease Week.

Biopharmaceutical company OrphoMed announced that the FDA has granted Fast Track status to speed development of its drug candidate for diarrhea-predominant irritable bowel syndrome.

April is IBS Awareness Month. First designated by the International Foundation for Functional Gastrointestinal Disorders in 1997, this initiative aims to raise awareness of the 10% to 15% of Americans who experience the symptoms of irritable bowel syndrome, an “often misunderstood and stigmatized condition,” according to the IFFGD.

In a genome-wide association study, investigators linked irritable bowel syndrome to certain DNA variants found only in women, which researchers said could explain why the condition is less common in men.

Primary care physicians need to discuss the risks and dangers of using NSAIDs with their patients, several doctors told Healio Family Medicine.

Analyte Health announced that it now offers a new test to help health care providers determine if a patient has inflammatory bowel disease or irritable bowel syndrome, according to a press release.

LAS VEGAS — Patients with moderate-to-severe Crohn’s disease achieved clinical response with Xifaxan, an antibiotic with limited systemic absorption approved for the treatment of diarrhea-predominant irritable bowel syndrome, according to new research presented at the Crohn’s & Colitis Congress.

Vitamin D could be effective in treating the painful symptoms associated with irritable bowel syndrome, according to a study published in The European Journal of Clinical Nutrition.